Morgan Stanley’s Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer APSG.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-15,193
Closed -$21K 8268
2022
Q1
$21K Hold
15,193
﹤0.01% 7140
2021
Q4
$19K Buy
15,193
+4,121
+37% +$4.32K ﹤0.01% 7234
2021
Q3
$9K Hold
11,072
﹤0.01% 7380
2021
Q2
$13K Buy
11,072
+10,143
+1,092% +$11.4K ﹤0.01% 7169
2021
Q1
$1K Buy
+929
New +$1.8K ﹤0.01% 7445

Morgan Stanley's APSG.WS Position: Q2 2022 in Review

Morgan Stanley sold out of Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer (APSG.WS) in Q2 2022, closing a stake of 15,193 shares — an estimated $21K sold.

Morgan Stanley first reported a position in APSG.WS in Q1 2021 and held it in 5 quarters. The position peaked at $21K in Q1 2022. 0 funds tracked by Wall St. Rank hold APSG.WS as of Q2 2022.

  • Morgan Stanley reported no remaining Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer position as of Q2 2022 after selling out during the quarter.
  • Morgan Stanley sold 15,193 Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer shares in Q2 2022, an estimated $21K.
  • Morgan Stanley first reported a position in Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer in Q1 2021 and held it in 5 quarters.
  • Morgan Stanley's Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer position peaked at $21K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer as of Q2 2022.

Based on Morgan Stanley's 13F filing for Q2 2022, filed 15 Aug 2022.